UAB Digital Repository of Documents 174 records found  1 - 10nextend  jump to record: Search took 0.01 seconds. 
1.
10 p, 531.5 KB Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases / Del Pozo, Victoria (Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)) ; Bobolea, Irina (Hospital Clínic i Provincial de Barcelona) ; Rial, Manuel J. (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES)) ; Espigol-Frigolé, Georgina (Hospital Clínic i Provincial de Barcelona) ; Solans, Roser (Hospital Universitari Vall d'Hebron) ; Hernández Rivas, Jesús María (Hospital Universitario de Salamanca) ; Mora, Elvira (La Fe University and Polytechnic Hospital) ; Crespo Lessmann, Astrid (Hospital de la Santa Creu i Sant Pau) ; Izquierdo Alonso, José Luis (Guadalajara University Hospital) ; Domínguez Sosa, María Sandra (University Hospital of Gran Canaria Dr. Negrín) ; Maza-Solano, Juan (University Hospital, Sevilla) ; Atienza-Mateo, Belén (Instituto de Investigación Marqués de Valdecilla (IDIVAL)) ; Bañas-Conejero, David (Specialty Care Medical Department, GSK) ; Moure, Abraham L. (Specialty Care Medical Department, GSK) ; Rua Figueroa, Íñigo (University Hospital of Gran Canaria Dr. Negrín) ; Universitat Autònoma de Barcelona. Departament de Medicina
Eosinophil-related diseases represent a group of pathologic conditions with highly heterogeneous clinical presentation and symptoms ranging from mild to critical. Both systemic and localized forms of disease are typically treated with glucocorticoids. [...]
2024 - 10.3389/fimmu.2023.1310211
Frontiers in immunology, Vol. 14 (january 2024)  
2.
10 p, 598.4 KB Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome : a 3-year follow-up cohort study / Park, Hye-Sang (Institut de Recerca Sant Pau) ; Martinez-Martinez, Laura (Institut de Recerca Sant Pau) ; Magallares López, Berta Paula (Institut de Recerca Sant Pau) ; Castellvi, Ivan (Institut de Recerca Sant Pau) ; Moya, Patricia (Institut de Recerca Sant Pau) ; Codes-Mendez, Helena (Institut de Recerca Sant Pau) ; Hernández-de Sosa, Nerea (Institut de Recerca Sant Pau) ; Díaz Torne, César (Institut de Recerca Sant Pau) ; Laiz, Ana (Institut de Recerca Sant Pau) ; Sainz, Luis (Institut de Recerca Sant Pau) ; Tandaipan, Jose Luis (Institut de Recerca Sant Pau) ; Mariscal, Anaís (Institut de Recerca Sant Pau) ; Franco-Leyva, Teresa (Institut de Recerca Sant Pau) ; Casademont i Pou, Jordi (Institut de Recerca Sant Pau) ; Juarez, Candido (Institut de Recerca Sant Pau) ; Corominas, Hèctor (Institut de Recerca Sant Pau) ; Universitat Autònoma de Barcelona
This was an ambispective cohort study evaluating the prognostic significance of lymphocytic foci and its lymphoid composition in minor salivary gland biopsy (MSGB) for short-term disease flare and severity in Sjögren's syndrome (SS). [...]
2024 - 10.3389/fimmu.2024.1332924
Frontiers in immunology, Vol. 15 (february 2024)  
3.
2 p, 292.1 KB Corrigendum : The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782) / Navarro-Compán, Victoria (Hospital Universitario La Paz (Madrid)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ; Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ; Llamas-Velasco, Mar (Hospital Universitario de la Princesa (Madrid)) ; Fernández-Carballido, Cristina (Hospital Universitario San Juan de Alicante) ; Almodóvar, Raquel (Hospital Universitario Fundación Alcorcón) ; Pinto, José Antonio (Complejo Hospitalario Universitario de A Coruña) ; Galíndez-Aguirregoikoa, Eva (Hospital Universitario de Basurto) ; Zarco, Pedro (Hospital Universitario Fundación Alcorcón) ; Joven, Beatriz (Hospital 12 de Octubre (Madrid)) ; Gratacós, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Juanola, Xavier (Hospital Universitari de Bellvitge) ; Blanco, Ricardo (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Arias-Santiago, Salvador (Universidad de Granada) ; Sanz Sanz, Jesús (Hospital Universitario Puerta del Hierro Majadahonda) ; Queiro, Ruben (Hospital Universitario Central de Asturias) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
In the published article, there was an error in Table 1 as published. The cell corresponding to ixekizumab in HS must be yellow rather than green, since it is not approved for that indication, nor has phase 3 clinical development been published. [...]
2023 - 10.3389/fimmu.2023.1332177
Frontiers in immunology, Vol. 14 (2023) , p. 1332177  
4.
11 p, 3.9 MB Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes / Arderiu, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Peña, Esther (Instituto de salud Carlos III) ; Civit-Urgell, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
We have recently shown that in ischemic tissue, the hypoxic endothelial cells (EC) release extracellular microvesicles (EMVs) that are rich in tissue factor (TF). These TF-EMVs induce monocyte (Mo) homing to the ischemic zone, their differentiation into EC-like cells, and the formation of new blood vessels increasing tissue perfusion. [...]
2022 - 10.3389/fimmu.2022.836662
Frontiers in immunology, Vol. 13 (18 2022) , p. 836662  
5.
14 p, 4.2 MB The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases / Navarro-Compán, Victoria (Hospital Universitario La Paz (Madrid)) ; Puig Sanz, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ; Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ; Llamas-Velasco, Mar (Hospital Universitario de la Princesa (Madrid)) ; Fernández-Carballido, Cristina (Hospital Universitario San Juan de Alicante) ; Almodóvar, Raquel (Hospital Universitario Fundación Alcorcón) ; Pinto, José Antonio (Complejo Hospitalario Universitario de A Coruña) ; Galíndez-Aguirregoikoa, Eva (Hospital Universitario de Basurto) ; Zarco, Pedro (Hospital Universitario Fundación Alcorcón) ; Joven, Beatriz (Hospital 12 de Octubre (Madrid)) ; Gratacós, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Juanola, Xavier (Hospital Universitari de Bellvitge) ; Blanco, Ricardo (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Arias-Santiago, Salvador (Universidad de Granada) ; Sanz Sanz, Jesús (Hospital Universitario Puerta del Hierro Majadahonda) ; Queiro, Ruben (Hospital Universitario Central de Asturias) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Interleukin-17 family (IL-17s) comprises six structurally related members (IL-17A to IL-17F); sequence homology is highest between IL-17A and IL-17F, displaying certain overlapping functions. In general, IL-17A and IL-17F play important roles in chronic inflammation and autoimmunity, controlling bacterial and fungal infections, and signaling mainly through activation of the nuclear factor-kappa B (NF-κB) pathway. [...]
2023 - 10.3389/fimmu.2023.1191782
Frontiers in immunology, Vol. 14 (august 2023)  
6.
12 p, 1.3 MB Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis : a real-world multicenter experience from Spain / Valero-Martínez, Cristina (Hospital Universitario de La Princesa) ; Urgelles, Judit Font (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sallés, Meritxell (Althaia Xarxa Assistencial Universitària) ; Joven-Ibáñez, Beatriz E. (Hospital 12 de Octubre (Madrid)) ; de Juanes, Alexia (Hospital 12 de Octubre (Madrid)) ; Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ; Juanola, Xavier (Hospital Universitari de Bellvitge) ; Almodóvar, Raquel (Hospital Universitario Fundación Alcorcón) ; Laiz, Ana (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Moreno Martínez-Losa, Mireia (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Pujol, Manel (Hospital Universitari MútuaTerrassa) ; Beltran Catalan, Emma (Hospital del Mar (Barcelona, Catalunya)) ; Pinto-Tasende, José Antonio (Hospital Universitario de A Coruña) ; Crespí, Laura (Hospital de Manacor) ; Sala-Icardo, Luis (Hospital de Torrejón de Ardoz) ; Castañeda, Santos (Universidad Autónoma de Madrid) ; García-Vicuña, Rosario (Universidad Autónoma de Madrid) ; Universitat Autònoma de Barcelona
Dual targeted therapy (DTT) has emerged as a promising approach in patients with refractory spondyloarthritis (SpA) or psoriatic arthritis (PsA) and extra-musculoskeletal manifestations of both diseases, but its effectiveness/safety ratio still remains unclear. [...]
2023 - 10.3389/fimmu.2023.1283251
Frontiers in immunology, Vol. 14 (october 2023)  
7.
11 p, 2.7 MB Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control / Masip, Jenifer (Hospital Universitari Joan XXIII de Tarragona) ; Rallón, Norma (Hospital Universitario Rey Juan Carlos (Madrid)) ; Yeregui, Elena (Hospital Universitari Joan XXIII de Tarragona) ; Olona, Montserrat (Hospital Universitari Joan XXIII de Tarragona) ; Resino, Salvador (Instituto de Salud Carlos III) ; Benito, José M. (Hospital Universitario Rey Juan Carlos (Madrid)) ; Viladés, Consuelo (Instituto de Salud Carlos III) ; García-Pardo, Graciano (Hospital Universitari Joan XXIII de Tarragona) ; Alcami, Jose (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ruiz-Mateos, Ezequiel (Universidad de Sevilla) ; Gómez-Bertomeu, Frederic (Hospital Universitari Joan XXIII de Tarragona) ; Vargas, Montserrat (Hospital Universitari Joan XXIII de Tarragona) ; Navarro, Marta (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Oteo, José A. (Hospital Universitario San Pedro) ; Pineda, Juan A. (Unidad de Investigación Hospital Universitario de Valme) ; Martí, Anna (Hospital Universitari Joan XXIII de Tarragona) ; Alba, Verónica (Hospital Universitari Joan XXIII de Tarragona) ; Vidal, Francesc (Instituto de Salud Carlos III) ; Peraire, Joaquin (Instituto de Salud Carlos III) ; Rull, Anna (Instituto de Salud Carlos III) ; Universitat Autònoma de Barcelona
Long-term elite controllers (LTECs) are a fascinating small subset of HIV individuals with viral and immunological HIV control in the long term that have been designated as models of an HIV functional cure. [...]
2022 - 10.3389/fimmu.2022.822272
Frontiers in immunology, Vol. 13 (april 2022)  
8.
22 p, 2.9 MB Advancing CART therapy for acute myeloid leukemia : recent breakthroughs and strategies for future development / Pérez-Amill, Lorena (Department of Immunology. Centre de Diagnòstic Biomèdic (CDB). Hospital Clínic de Barcelona) ; Bataller, Alex (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Delgado, Julio (Universitat de Barcelona) ; Esteve, Jordi (Universitat de Barcelona) ; Juan, Manel (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Klein-González, Nelia (Hospital Clínic i Provincial de Barcelona)
Chimeric antigen receptor (CAR) T therapies are being developed for acute myeloid leukemia (AML) on the basis of the results obtained for other haematological malignancies and the need of new treatments for relapsed and refractory AML. [...]
2023 - 10.3389/fimmu.2023.1260470
Frontiers in immunology, Vol. 14 (2023) , p. 1260470  
9.
9 p, 1.2 MB Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma / Gonzalez-Montes, Yolanda (Universitat de Girona) ; Rodriguez-Romanos, Rocío (Universitat de Girona) ; Villavicencio, Alicia (Universitat de Girona) ; Osca-Gelis, Gemma (Universitat de Girona) ; González-Bártulos, Marta (Universitat de Girona) ; Llopis, Francesca (Universitat de Girona) ; Clapes, Victòria (Hospital Universitari de Bellvitge) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sureda, Anna (Hospital Universitari de Bellvitge) ; Escoda, Lourdes (Universitat Rovira i Virgili) ; Sarrà, Josep (Universitat Rovira i Virgili) ; Garzó, Ana (Universitat de Girona) ; Lloveras, Natàlia (Universitat de Girona) ; Díez, Isabel (Universitat de Girona) ; Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gallardo, David (Universitat de Girona)
Immune dysfunction in patients with multiple myeloma (MM) affects both the innate and adaptive immune system. Molecules involved in the immune checkpoint pathways are essential to determine the ability of cancer cells to escape from the immune system surveillance. [...]
2023 - 10.3389/fimmu.2023.1158105
Frontiers in immunology, Vol. 14 (april 2023)  
10.
16 p, 2.1 MB Brewpitopes : a pipeline to refine B-cell epitope predictions during public health emergencies / Farriol-Duran, Roc (Barcelona Supercomputing Center) ; López-Aladid, Ruben (Pneumology Department. Hospital Clínic) ; Porta-Pardo, Eduard (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Torres, Antoni (Hospital Clínic i Provincial de Barcelona) ; Fernández-Barat, Laia (Hospital Clínic i Provincial de Barcelona)
The application of B-cell epitope identification to develop therapeutic antibodies and vaccine candidates is well established. However, the validation of epitopes is time-consuming and resource-intensive. [...]
2023 - 10.3389/fimmu.2023.1278534
Frontiers in immunology, Vol. 14 (2023) , p. 1278534  

UAB Digital Repository of Documents : 174 records found   1 - 10nextend  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.